SCHEMBL5735129

SCHEMBL5735129

O=C(O)Oc1c[nH]c2c(C3CC3)c(N3CCNCC3)c(F)cc2c1=O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.39
ALDH1A1 P00352 6/20 0.39
HPGD P15428 6/20 0.39
HSD17B10 Q99714 6/20 0.39
TOP2A P11388 5/20 0.39
LMNA P02545 5/20 0.39
TOP2B Q02880 4/20 0.39
CYP2C9 P11712 2/20 0.39
CYP1A2 P05177 1/20 0.39
TOP1 P11387 1/20 0.35
BRD4 O60885 1/20 0.35
TSHR P16473 1/20 0.35
HTT P42858 1/20 0.35
CYP2J2 P51589 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
ATP6V1B2 P21281 1/20 0.34
TBXA2R P21731 1/20 0.34
EDNRA P25101 1/20 0.34
TARBP2 Q15633 1/20 0.34
POLB P06746 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5736019 0.89 KDM4E (0.41) KDM4EALDH1A1HPGDHSD17B10TOP2A
SCHEMBL3239412 0.87 KDM4E (0.48) KDM4EALDH1A1HPGDHSD17B10TOP2A
SCHEMBL5507782 0.87 KDM4E (0.41) KDM4EALDH1A1HPGDHSD17B10LMNA
Hydrochloric Acid SCHEMBL7253434 0.85 KDM4E (0.46) KDM4EALDH1A1HPGDHSD17B10TOP2A
SCHEMBL9378968 0.81 KDM4E (0.39) KDM4EALDH1A1HPGDHSD17B10TOP2A
SCHEMBL6903795 0.81 CYP1A2 (0.47) KDM4EALDH1A1HPGDHSD17B10LMNA
SCHEMBL6676409 0.80 CSNK2A2 (0.33) ALDH1A1LMNA
SCHEMBL1498578 0.79 PLAT (0.41) KDM4EALDH1A1HPGDHSD17B10TOP2A
SCHEMBL4744115 0.77 KDM4E (0.40) KDM4EALDH1A1HPGDHSD17B10TOP2A
SCHEMBL8898775 0.76 KDM4E (0.50) KDM4EALDH1A1HPGDHSD17B10TOP2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1282422-A1 CIPROFLOXACIN INFUSION SOLUTIONS WITH IMPROVED STORAGE LIFE Fresenius Kabi Deutschland GmbH (DE) 2003-02-12 EP claimed
WO-2001078731-A1 CIPROFLOXACIN INFUSION SOLUTIONS WITH IMPROVED STORAGE LIFE FRESENIUS KABI DEUTSCHLAND GMBH (DE) 2001-10-25 WO claimed
EP-1682144-A1 PHARMACEUTICAL FORMULATIONS CONTAINING FLAVOURING SUBSTANCES WITH IMPROVED PHARMACEUTICAL PROPERTIES Bayer HealthCare AG (DE) 2006-07-26 EP disclosed
WO-2005044271-A1 PHARMACEUTICAL FORMULATIONS CONTAINING FLAVOURING SUBSTANCES WITH IMPROVED PHARMACEUTICAL PROPERTIES BAYER HEALTHCARE AG (DE) 2005-05-19 WO disclosed
EP-1320368-A1 INFUSION OF CIPROFLOXACIN HAVING REDUCED ACID CONTENT AND BEING STABLE IN STORAGE Fresenius Kabi Deutschland GmbH (DE) 2003-06-25 EP disclosed
EP-1282422-A1 CIPROFLOXACIN INFUSION SOLUTIONS WITH IMPROVED STORAGE LIFE Fresenius Kabi Deutschland GmbH (DE) 2003-02-12 EP disclosed
WO-2002026233-A1 INFUSION OF CIPROFLOXACIN HAVING REDUCED ACID CONTENT AND BEING STABLE IN STORAGE FRESENIUS KABI DEUTSCHLAND GMBH (DE) 2002-04-04 WO disclosed
WO-2001078731-A1 CIPROFLOXACIN INFUSION SOLUTIONS WITH IMPROVED STORAGE LIFE FRESENIUS KABI DEUTSCHLAND GMBH (DE) 2001-10-25 WO disclosed
WO-1999002160-A1 HIGH-PURITY CIPROFLOXACINE SOLUTIONS FOR INFUSION BAYER AKTIENGESELLSCHAFT (DE) 1999-01-21 WO disclosed
EP-0238814-A2 Antibacterial medicaments for fish BAYER AG (DE) 1987-09-30 EP disclosed
EP-0230881-A2 Pharmaceutical preparations containing ciprofloxacin BAYER AG (DE) 1987-08-05 EP disclosed